These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37138146)

  • 1. A novel pyroptosis-associated lncRNA LINC01133 promotes pancreatic adenocarcinoma development via miR-30b-5p/SIRT1 axis.
    Li J; Lin J; Ji Y; Wang X; Fu D; Wang W; Shen B
    Cell Oncol (Dordr); 2023 Oct; 46(5):1381-1398. PubMed ID: 37138146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissection of pyroptosis-related prognostic signature and CASP6-mediated regulation in pancreatic adenocarcinoma: new sights to clinical decision-making.
    Zhu J; Shi Y; Lan S; Wang J; Jiang F; Tang C; Cai Y; Pan Z; Jian H; Fang H; Zhang Y; Zhong F
    Apoptosis; 2023 Jun; 28(5-6):769-782. PubMed ID: 36882663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
    Yan C; Niu Y; Li F; Zhao W; Ma L
    J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
    Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
    Front Immunol; 2022; 13():854785. PubMed ID: 35392086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comprehensive Analysis of Pyroptosis-Related lncRNAs Signature Associated With Prognosis and Tumor Immune Microenvironment of Pancreatic Adenocarcinoma.
    Zhao K; Li X; Shi Y; Lu Y; Qiu P; Deng Z; Yao W; Wang J
    Front Genet; 2022; 13():899496. PubMed ID: 35873495
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor mutation burden-related long non-coding RNAs is predictor for prognosis and immune response in pancreatic cancer.
    Wang C; Wang Z; Zhao Y; Jia R
    BMC Gastroenterol; 2022 Nov; 22(1):495. PubMed ID: 36451085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression.
    Li T; Zhao H; Zhou H; Geng T
    PLoS One; 2021; 16(3):e0247817. PubMed ID: 33661995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PANoptosis-related long non-coding RNA signature to predict the prognosis and immune landscapes of pancreatic adenocarcinoma.
    Zhao Q; Ye Y; Zhang Q; Wu Y; Wang G; Gui Z; Zhang M
    Biochem Biophys Rep; 2024 Mar; 37():101600. PubMed ID: 38371527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome instability-related LINC02577, LINC01133 and AC107464.2 are lncRNA prognostic markers correlated with immune microenvironment in pancreatic adenocarcinoma.
    Zhang Y; Wang Y; He X; Yao R; Fan L; Zhao L; Lu B; Pang Z
    BMC Cancer; 2023 May; 23(1):430. PubMed ID: 37173624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma.
    Li J; Li W; Wang H; Ni B; Liu Y
    Mol Med Rep; 2023 Feb; 27(2):. PubMed ID: 36660936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinoma.
    Huang Q; Peng X; Li Q; Zhu J; Xue J; Jiang H
    Front Immunol; 2023; 14():1111494. PubMed ID: 36817451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated analysis identifies cuproptosis-related gene DLAT and its competing endogenous RNAs network to predict the prognosis of pancreatic adenocarcinoma patients.
    Zhou C; Jin L; Yu J; Gao Z
    Medicine (Baltimore); 2024 Mar; 103(9):e37322. PubMed ID: 38428843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a novel N6-methyladenosine (m6A)-related multi- long non-coding RNA (lncRNA) prognostic signature in pancreatic adenocarcinoma.
    Yuan Q; Ren J; Li L; Li S; Xiang K; Shang D
    Bioengineered; 2021 Dec; 12(1):2432-2448. PubMed ID: 34233576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Noncoding RNA LINC01133 Promotes the Malignant Behaviors of Renal Cell Carcinoma by Regulating the miR-30b-5p/Rab3D Axis.
    Zhai X; Wu Y; Wang Z; Zhao D; Li H; Chong T; Zhao J
    Cell Transplant; 2020; 29():963689720964413. PubMed ID: 33054325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC01232 Sponges Multiple miRNAs and Its Clinical Significance in Pancreatic Adenocarcinoma Diagnosis and Prognosis.
    Du W; Lei C; Wang Y; Ding Y; Tian P
    Technol Cancer Res Treat; 2021; 20():1533033820988525. PubMed ID: 33506742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An innovative pyroptosis-related long-noncoding-RNA signature predicts the prognosis of gastric cancer
    Xiong S; Jin L; Zeng C; Ma H; Xie L; Liu S
    Pathol Oncol Res; 2022; 28():1610712. PubMed ID: 36567977
    [No Abstract]   [Full Text] [Related]  

  • 17. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of cuproptosis-related lncRNAs associated with pancreatic cancer immune microenvironment based on single-cell.
    Sun Y; Yao L; Man C; Gao Z; He R; Fan Y
    Front Immunol; 2023; 14():1220760. PubMed ID: 37822927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a Novel Pyroptosis-Associated lncRNA Biomarker Signature in Lung Adenocarcinoma.
    Wang P; Wang Z; Lin Y; Castellano L; Stebbing J; Zhu L; Peng L
    Mol Biotechnol; 2024 Feb; 66(2):332-353. PubMed ID: 37154865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA SNHG17 contributes to the progression of pancreatic adenocarcinoma by modulating miR-32-5p/EZH2/STAT3 signaling.
    Ying L; Wang J; Feng J; Wu Z
    Mol Biol Rep; 2023 Jul; 50(7):5941-5947. PubMed ID: 37253918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.